(PRWEB) December 20, 2012
The US Drug Watchdog fears that the vast majority of diabetics in the United States have never heard about a diabetes drug called Actos, and an elevated risk of bladder cancer from this drug. The group also fears that many US diabetics may have already died from bladder cancer, after using the diabetes drug called Actos. The group says, "We want to help every user of the diabetes drug called Actos, if they have developed bladder cancer, and we are certain we will need the assistance of family members, friends or loved ones to help us get these Actos user-bladder cancer victims identified. France, and Germany banned sales of Actos on July 11th 2011, because of bladder cancer associated with this drug. We are urging every US diabetic, who was using the diabetes drug, and now has bladder cancer to call the Johnson Law Group at 1-800-996-9900." http://www.johnsonlawgroup.com/
According to the AP, "The FDA has issued a warning that Actos may be linked to an increased risk of bladder cancer. Meanwhile, both Germany and France have suspended sales of Actos. The Actos suspension became effective July 11, 2011. Actos, along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who were taking the medication." The US Drug Watchdog says, "We want any user of the diabetes medication called Actos, who then developed bladder cancer to call the Johnson Law Group at 1-800-996-9900. Time really is of the essence." http://www.johnsonlawgroup.com/
The US Drug Watchdog says, "One of the biggest problems we have with respect to our drug initiative work, is the average US consumer never hears about a drug recall, or serious side effects related to a specific drug's use. We are attempting to change this very sad fact with aggressive initiatives focused on increasing public awareness, and hopefully suggesting possible help for victims." http://USDrugWatchdog.Com
Case number 11cv2406 BEN BGS in the Federal District Court San Diego, CA.
Read the full story at http://www.prweb.com/releases/2012/12/prweb10214169.htm.
Copyright©2012 Vocus, Inc.
All rights reserved